## **Core Concept**
Marijuana, or more specifically its active components like **tetrahydrocannabinol (THC)**, has been studied for its potential therapeutic effects on various conditions, including **AIDS-related cachexia**. Cachexia is a condition characterized by weight loss, muscle atrophy, fatigue, weakness, and loss of appetite in someone who is not actively trying to lose weight.

## **Why the Correct Answer is Right**
The correct answer, , involves the use of **dronabinol**, a synthetic form of THC, which has been shown to stimulate appetite and promote weight gain in patients with AIDS-related cachexia. THC acts on the **cannabinoid receptors** in the brain, which are involved in regulating appetite, among other functions. By activating these receptors, THC can help increase appetite and caloric intake, thereby addressing one of the main issues in cachexia.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because while **corticosteroids** can have various effects on the body, including influencing appetite and metabolism, they are not specifically indicated for AIDS-related cachexia as a first-line treatment and can have significant side effects.
- **Option B:** This option is incorrect as there is no widely recognized treatment or substance by this name related to the treatment of AIDS-related cachexia.
- **Option C:** This option might seem plausible because **non-steroidal anti-inflammatory drugs (NSAIDs)** can help with pain management, but they do not directly address the core issue of cachexia, which is loss of appetite and muscle wasting.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **dronabinol**, a cannabinoid receptor agonist, is specifically approved by the FDA for the treatment of **AIDS-related cachexia** and **chemotherapy-induced nausea and vomiting**. This highlights the therapeutic potential of cannabinoids in managing certain symptoms associated with chronic diseases and treatments.

## **Correct Answer:** . Dronabinol.